Streptokinase (streptokinase): Reviews and patient testimonials

Streptokinase 1,500,000 iu

Biofactor Streptokinase is indicated in adults.

Acute myocardial infarction: within 12 hours of onset with persistent ST-segment elevation or recent left bundle-branch block. Note: No statement on therapy outcome can be made for administration beyond the time window indicated above.

Streptokinase 250,000 iu

Biofactor Streptokinase is indicated in adults.

Biofactor Streptokinase is a fibrinolytic agent which may be used for the intravascular dissolution of thrombi and emboli in:

- acute massive pulmonary embolism

- acute, sub-acute or chronic (not older than 6 weeks) occlusion of peripheral arteries

- extensive deep vein thrombosis

- central retinal venous or arterial thrombosis (arterial occlusions not older than 8 hours, venous occlusions not older than 10 days).

Note: No statement on therapy outcome can be made for administration beyond the time windows indicated above.

Streptokinase 750,000 iu

Biofactor Streptokinase is indicated in adults.

Biofactor Streptokinase is a fibrinolytic agent which may be used for the intravascular dissolution of thrombi and emboli in:

- acute massive pulmonary embolism

- acute, sub-acute or chronic (not older than 6 weeks) occlusion of peripheral arteries

- extensive deep vein thrombosis

- central retinal venous or arterial thrombosis (arterial occlusions not older than 8 hours, venous occlusions not older than 10 days).

Note: No statement on therapy outcome can be made for administration beyond the time windows indicated above.

Molecule: streptokinase